Final-Program-ATS-2023-AP.vp

TUESDAY • MAY 23

283

Target Audience Researchers, medical trainees, those with an interest in COPD pathogenesis Objectives At the conclusion of this session, the participant will be able to: • learn about natural history of smokers with respiratory symptoms • learn about biomarkers of COPD • learn about social determinants influence on respiratory outcomes SPIROMICS II is an NHLBI-sponsored study that supports the prospective collection and analysis of phenotypic, biomarker, genetic, genomic, and clinical data from subjects with COPD for the purpose of identifying subpopulations and the biological underpinnings of clinical phenotypes in COPD. Participants in this session will learn about the progress in SPIROMICS II including results and analyses of data. Chairing: L. Postow, PhD, Bethesda, MD P. Woodruff, MD, MPH, San Francisco, CA 12:00 Redefining Therapy in Early COPD (RETHINC) M.K. Han, MD, MS, ATSF, Ann Arbor, MI 12:12 Bronchodilator Responsiveness in Smoked Tobacco-Exposed Persons with or without COPD S. Fortis, MD, Iowa City, IA 12:24 Variation in Mendelian Genes and Risk for COPD V.E. Ortega, MD, PhD, ATSF, Scottsdale, AZ 12:36 Clinical Relevance of Airway Mucin (MUC5AC and

MTE40 CYSTIC FIBROSIS: CLINICAL CHALLENGES IN THE ERA OF HIGHLY EFFECTIVE MODULATOR THERAPY C.M. Bojanowski, MD, MSCR, New Orleans, LA Howard University (Level M1) MTE42 SMOKING RELATED INTERSTITIAL LUNG DISEASES M. Porteous, MD, MSCE, Philadelphia, PA University of DC/Catholic University (Level M1) MTE43 ORGANS-ON-CHIPS FOR THE LUNGS: PAST, CURRENT AND FUTURE K. Hajipouran Benam, PhD, Pittsburgh, PA LeDroit Park (Level M3) MTE44 VIRTUAL PULMONARY REHABILITATION: IDENTIFYING KEY STRATEGIES AND CONQUERING THE CHALLENGES TO ESTABLISHING A SUCCESSFUL PROGRAM S.K. Huang, MD, Ann Arbor, MI Mount Vernon Square (Level M3) MTE45 CENTRAL SLEEP APNEA, PATHOPHYSIOLOGICAL CLASSIFICATION AND RELATED MANAGEMENT S. Javaheri, MD, Cincinnati, OH Chinatown (Level M3)

MUC5B) Concentrations in COPD J. Kim, MD, MS, Charlottesville, VA 12:48 SPIROMICS Review and Summary

P. Woodruff, MD, MPH, San Francisco, CA

MEET THE EXPERT SEMINARS CME Credits Available: 1

R Pre-registration and additional fees required. Attendance is limited. $100 Member/Non-Members $70 LMIC Member/LMIC Non-Members 12:00 p.m. - 1:00 p.m. Marriott Marquis Washington MTE37 EXERCISE TEST IN NEW ERA: UPDATED QUALITY IN PULMONARY REHABILITATION AFTER COVID-19 N. Cox, PT, MSci, PhD, Melbourne, Australia Judiciary Square (Level M3) MTE38 REFRACTORY SARCOIDOSIS: WHEN AND HOW TO USE TNF-INHIBITORS

W.E. James, MD, Charleston, SC Gallaudet University (Level M1)

ATS 2023 • Washington, DC